Befejeződött1. fázis
Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
Key facts
- Where
- Aachen, Dresden, Hamburg, Leipzig, Marburg, Munich, Ulm és Wuerzburg, NémetországSee the 8 sites
- Phase
- 1. fázis
Where in Németország
- Universitaetsklinikum Aachen AöRAachen, NémetországNo longer taking part
- Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöRDresden, NémetországNo longer taking part
- University Medical Center Hamburg-EppendorfHamburg, NémetországNo longer taking part
- Universitaet LeipzigLeipzig, NémetországNo longer taking part
- Philipps-Universitaet MarburgMarburg, NémetországNo longer taking part
- Klinikum der Universitaet Muenchen AöRMunich, NémetországNo longer taking part
- Universitaetsklinikum Ulm AoRUlm, NémetországNo longer taking part
- Universitaetsklinikum Wuerzburg AöRWuerzburg, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AvenCell Europe GmbH
- Trial code
- EU 2024-515827-12-00
- Record updated
- 2025. január 23.